Tumor cell metabolism: the marriage of molecular genetics and proteomics with cellular intermediary metabolism; proceed with caution!
Metabolic transformations of malignant cells are essential to the development and progression of all cancers. The understanding of the pathogenesis and progression of cancer requires the establishment of the altered genetic/metabolic factors that are essential to the development, growth, and proliferation of the malignant cells. Recognition of this important relationship has resulted in a resurgence of interest in the intermediary metabolism of tumor cells. The role of molecular genetics and proteomics and the application of molecular technology in assessing altered cellular metabolism has become a major area of biomedical research. The contemporary generation of biomedical scientists is exceptionally well trained in all areas of molecular biology and molecular technology, which are now important tools to be applied to the regulation of cellular intermediary metabolism. Simultaneously, the didactic and methodological training associated with the principles and operation of metabolic pathways, enzymology, cellular enzyme activity, and associated biochemical implications has been diminished and often eliminated from the pre- and post-doctoral programs. Interpretations and conclusions of alterations in cellular enzyme activity and associated metabolic pathways based on genetic/proteomic changes can and will result in misrepresentation of important metabolic implications in malignancy and other diseases. It is essential that the genetic/proteomic studies be coupled to biochemical/metabolic cellular events to satisfy the axiom: "genetic transformations and proteomic alterations will have little relevancy to disease processes if the genetic/proteomic alterations are not manifested in altered and impaired cellular and metabolic function". The appropriate marriage of molecular genetics/proteomics with the regulation of cellular intermediary metabolism will provide new revelations and understanding of malignancy that could not be achieved in earlier generations.
Costello
Leslie C
LC
Department of Biomedical Sciences, Dental School, and the Greenebaum Cancer Center, University of Maryland, 650 West Baltimore Street, Baltimore, MD 21201, USA. lcostello@umaryland.edu
Franklin
Renty B
RB
D002471:Cell Transformation, Neoplastic / Q000378:metabolism; D020650:Combinatorial Chemistry Techniques / Q000379:methods*; D006801:Humans; D053858:Metabolic Networks and Pathways / Q000502:physiology; D008954:Models, Biological; D008967:Molecular Biology / Q000379:methods*; D009369:Neoplasms / Q000378:metabolism*; D040901:Proteomics / Q000379:methods*; D012107:Research Design / Q000639:trends